|
 This site complies with the HONcode standard for trustworthy health information: verify here.
Rewarding for you and us Defeat Diabetes Foundation
Defeat Diabetes Foundation 150 153rd Ave, Suite 300 Madeira Beach, FL 33708
|
Research
Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.
The Four Main Risk Factors for PAD
Posted: Sunday, October 28, 2012
|
Four risk factors for peripheral arterial disease (PAD) account for the vast majority of cases.
|
Diabetes with Psoriasis Increases Vascular Risk
Posted: Tuesday, October 23, 2012
|
Patients with diabetes and psoriasis are significantly more likely to develop new-onset, diabetes-related microvascular and macrovascular complications than are psoriasis-free patients with diabetes.
|
Sleepless Nights Increase Risk for Diabetes
Posted: Tuesday, October 23, 2012
|
Sleep deprivation can affect insulin resistance.
|
Foot Ulceration for Diabetes Patients Doubles Mortality Risk
Posted: Monday, October 22, 2012
|
Diabetic foot ulceration was associated with a nearly 2-fold increased risk for all-cause mortality above that of diabetes alone, according to a meta-analysis of 8 studies.
|
Sitting for Too Long Doubles Diabetes Risk
Posted: Sunday, October 21, 2012
|
The more time people spend sitting, the greater their risk of diabetes, cardiovascular events, and death.
|
EASD: Increasing Physical Activity Slashes CV Events, Deaths by 66% for Type 2's
Posted: Tuesday, October 09, 2012
|
Higher levels of leisure-time physical activity cut the risk of cardiovascular and all-cause mortality in people with type 2 diabetes.
|
EASD: New EASD/ADA Position Paper Shifts Treatment Goals with 7 Key Points
Posted: Tuesday, October 09, 2012
|
A new position statement for treatment of type 2 diabetes treatment focuses on the individual patient rather than a "one number fits all" HbA1c target.
|
EASD: Once a Year Exenatide Introduced at EASD
Posted: Monday, October 08, 2012
|
Continuous long-term delivery of exenatide with Intarcia's osmotic mini-pump system allows optimal dose selection for improved glycemic control, ensures adherence, and improves patient tolerability.
|
EASD: Merck's Investigational Once-Weekly DPP-4 Inhibitor Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes
Posted: Monday, October 08, 2012
|
Merck announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.
|
L-cysteine a Possible Therapy for Type-2 Diabetes
Posted: Tuesday, October 02, 2012
|
Taking L-cysteine supplements may help patients with type 2 diabetes better control blood sugar levels.
|
|
Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.
 Send your unopened, unexpired test strips to:
Defeat Diabetes Foundation 150 153rd Ave, Suite 300 Madeira Beach, FL 33708

DDF advertisement

Friendly Banner
Friendly Banner
Analyze nutrition content by portion DDF advertisement
|